CNS Services provide human organoid studies for CNS safety and drug efficacy.
View competitors
28bio is a neurotechnology company that engineers human brain models exhibiting memory, learning, and cognitive functions.
Formerly AxoSim, 28bio is a neurotechnology company whose models reproduce memory, learning, and cognitive functions. It now operates under the name 28bio and engineers human brain models at scale, while neurological drug development suffers high failure rates because animal models translate poorly to humans.
Its Nexon platform integrates tissue engineering, neural interfacing, and artificial intelligence to engineer human brains at scale and replicate complex neurological processes. Endurance Study results outperform previously published data on 2D and 3D cell-based assays and animal models, and large pharmaceutical companies use the Nexon platform to improve the prediction of therapeutic efficacy and toxicity in humans.

NeuroX1
neurox1.com

Herophilus
herophilus.com

Quiver Bioscience

AcuraStem
acurastem.com

BioXcel Therapeutics

Novela Neurotech
novelaneuro.com

Exin Therapeutics

Parallel Bio
parallel.bio

AivoCode
aivocode.com

Rezo Therapeutics
rezotx.com

Axoft
axoft.us

NeuCyte
neucyte.com

AXONIS Therapeutics
axonis.us

Xontogeny
xontogeny.com

CN Bio
cn-bio.com

BioMap
biomap.com

NextVivo
nextvivo.bio

Reservoir Neuroscience
reservoirneuro.com

Unravel Biosciences
unravel.bio

Purr.ai
purrai.com
Companies similar to 28bio include NeuroX1, Herophilus, Quiver Bioscience and AcuraStem.
28bio was founded in 2014.
28bio's headquarters is located in New Orleans, LA, US.
28bio's most recent funding round was for $1.8M (USD) in May 2025.
As of May 21, 2025, 28bio has disclosed funding of $12.3M (USD).
28bio has 46 employees as of Feb 5, 2024.